Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

°æ±¸¿ë ºñ½ºÆ÷½ºÆ÷³×ÀÌÆ® Åõ¿© °ñ´Ù°øÁõ ȯÀÚ¿¡¼­ ÀÓÇöõÆ® º¯¿¬°ñ º¯È­¿¡ °üÇÑ ¿¬±¸

Marginal bone loss of dental implant in oral bisphosphonates taking patients with osteoporosis

Journal of Dental Implant Research 2013³â 32±Ç 2È£ p.40 ~ 44
³²±â¿í, ¾ÈÀç¸í, È«Á¾¶ô,
¼Ò¼Ó »ó¼¼Á¤º¸
³²±â¿í ( Nam Ki-Uk ) - ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ±¸°­¾Ç¾È¸é¿Ü°ú
¾ÈÀç¸í ( Ahn Jae-Myung ) - ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ±¸°­¾Ç¾È¸é¿Ü°ú
È«Á¾¶ô ( Hong Jong-Rak ) - ¼º±Õ°ü´ëÇб³ ÀÇ°ú´ëÇÐ »ï¼º¼­¿ïº´¿ø ±¸°­¾Ç¾È¸é¿Ü°ú

Abstract


Purpose: The relationship between oral bisphosphonate (BP) and marginal bone loss of implant and failure has not been fully examined. The aim of this study was to examine whether patients who take oral bisphosphonates decrease of implant failure rate and decrease marginal bone loss than non taking groups.

Materials and Methods: This study investigated the patients who had received dental implants and receiving oral BP therapy in Samsung Medical Center from January 1999 to December 2012. All patients received oral bisphosphonate before implant surgery before 3 years ago (Group 3) or under 3 years (Group 4) and Negative control group were healthy patients (Group 1), positive control group were the patients who had Diabete mellitus (Group 2).

Results: There were significant decreased success rate and marginal bone loss in Group 2. There was no difference between Group 1, 3 and 4 in success rate and marginal bone loss.

Conclusions: In this study, there is no significant difference in healthy and BPs taking group in marginal bone resorption around Dental Implants.

Å°¿öµå

Bisphosphonates; Dental implant; Osteoporosis

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

 

µîÀçÀú³Î Á¤º¸